Zurich Insurance Raises $5 Billion in Share Sale to Fund Beazley Takeover

Zurich Insurance Group has raised 3.9 billion Swiss francs ($5 billion) through a share sale to help finance its acquisition of British specialty insurer Beazley, the company said on Tuesday. The move prompted a sharp fall in Zurich’s share price.

The Swiss insurer placed 7.1 million new shares with a par value of 0.10 Swiss francs each at a price of 550 francs per share, according to a company statement. The transaction will increase Zurich’s share capital from 14.6 million francs to 15.3 million francs.

Zurich said the net proceeds from the placement would be used in part to fund its agreed takeover of Beazley. The remainder of the purchase price will be financed through existing cash resources and new debt facilities.

By 0840 GMT, Zurich shares were down 5.4 percent at 543 francs, marking their steepest single-day decline since April. The drop left the insurer at the bottom of Switzerland’s blue-chip index during morning trade, reflecting investor caution over the scale of the transaction and the dilution from the new shares.

The newly issued shares are expected to be listed and admitted to trading on the SIX Swiss Exchange on or around March 5.

On Monday, Zurich announced that Beazley shareholders had agreed to the terms of an £8.1 billion takeover offer. The deal represents a significant expansion of Zurich’s presence in the specialty insurance market, a segment that includes coverage for complex and high-risk areas such as cyber, marine and political risk.

Under the agreed terms, Beazley shareholders will receive 1,335 pence per share. The offer consists of 1,310 pence in cash along with a dividend of 25 pence per share.

Zurich has said the acquisition will strengthen its position in attractive specialty lines and broaden its underwriting capabilities. Investors, however, reacted cautiously to the funding structure and the size of the capital raise.

Market analysts noted that while the acquisition could enhance Zurich’s long-term growth prospects, the immediate impact of the share placement and additional debt weighed on sentiment. The transaction remains subject to regulatory approvals and customary closing conditions.

If completed, the deal would rank among the largest recent acquisitions in the European insurance sector and signal continued consolidation in the global specialty insurance market.